FTO and nonpapillary renal cell carcinoma: Importantly, in multivariable analysis, higher (>P25) FTO expression had a protective effect for pRCC patients progression as well as for overall survival in ccRCC and pRCC patients, whereas more advanced pathological stages associated with worse prognoses, as well as age at diagnosis, but only for overall survival in ccRCC patients (Table 1).